Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
Types of Multiple Myeloma | International Myeloma Foundation
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
PDF) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC
A) Ultrastructure of NCI-H929 | Download Scientific Diagram
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Cancers | Free Full-Text | The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis | HTML
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomib - Sevilla‐Movilla - 2020 - The Journal of Pathology - Wiley Online Library
A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases | Gene Therapy
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics | Molecular Pharmaceutics
plus dead) labeled
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients - Experimental Hematology
Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus Biologicals
